Search for: "ADVANCED MARKETING SYSTEMS v. WALGREEN CO. "
Results 1 - 12
of 12
Sorted by Relevance
|
Sort by Date
5 Jun 2017, 4:00 am
Advanced Marketing Systems, LLC, Case CBM2016-00013, Patent 8,538,805 B2 (PTAB May 24, 2017); Walgreen Co. v. [read post]
20 Nov 2015, 10:03 am
From the cases: NY & R Cement Co v. [read post]
11 Jan 2010, 4:08 pm
Riyad; Eureka Water Co. v. [read post]
9 Apr 2015, 5:00 am
Walgreen Co., 264 P.3d 1155, 1159 (Nev. 2011), as have two state intermediate courts of appeal. [read post]
13 Oct 2008, 12:12 pm
Patent landscape analytics may prove you wrong (IP Asset Maximizer Blog) Why sinking markets could mean real opportunities for patent acquirers and licensees (IAM) Global - Copyright Copyright still viable, at least for top authors (IP finance) Understanding the backlash cost in copying someone else's work (Techdirt) Africa Designers from all OAPI (Organisation Africaine de la Propriete Intellectuelle) countries to benefit from fee reductions (Afro-IP) (WIPO)… [read post]
3 Feb 2011, 2:11 pm
Bristol-Myers Squibb Co., 121 F. [read post]
5 Sep 2008, 11:01 pm
& Ors v Deisel Spa and Case C-302/08 Zino Davidoff SA v Bendesfinanzdirektion Sudost: (Class 46), EPO Boards of Appeal finds that when a fax is transmitted and an ‘OK’ is noted by the sender, this is evidence that the transmission was successful: (IPKat), Professor Hugenholtz slams European Commission for ignoring evidence on copyright extension: (Techdirt) Germany Federal Patent Court publishes guidelines on colour trade mark Signal Yellow:… [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
4 May 2023, 9:05 pm
Investing to advance a societal goal constitutes a mixed motive, a fiduciary violation.[2] The attorneys general of a number of states have drafted legal opinions prohibiting their public entities from ESG investing on this basis.[3] These opinions rely on an assumption that ESG investing is non-pecuniary and therefore entails a mixed motive. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
13 Aug 2020, 6:59 am
Federal Reserve, where details (a roadmap, really) of FedNow, the proposed instant payment system, were released earlier this month. [read post]
